Find the Difference: Drug-Related Psoriasis
Lack of specific phenotypes complicates verification.
French Results Echo Expert Findings
According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.
PeDRA Lists Systemics With Higher COVID-19 Risk
Some systemic medications may have increased risk for patients during the COVID-19 era, according to a recent Pediatric Dermatology Research Alliance (PeDRA) statement.
Studies of Commonly Used Supplements for Psoriasis
Theresa Vavra, PharmD, BCPS, provides studies for some of the most commonly used supplements by patients with psoriasis.
3 Dietary Considerations for Psoriasis
Whitney Linsenmeyer, PhD, RD, LD, provides 3 dietary considerations for patients with psoriasis.
Transform Pandemic Lessons Into Actionable Care Plans
COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.
Patients Share Experience with Dietary Interventions, Supplement Use
Holistic options for disease management show improvement in mild psoriasis.
Psoriasis, Metabolic Syndrome Connection Expands
Due to the multimorbid nature of the disease, clinicians must screen, monitor, and aggressively treat the associated comorbidities.
